Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMPASTONE Trial
NCT06653738Phase 3Recruiting
- Sponsor
- Insel Gruppe
- Start
- Jul 2026
- Primary completion
- Sep 2030
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of empagliflozin in nephrolithiasis, sponsored by Insel Gruppe. Started Jul 2026; status: recruiting.
02
Drugs
empagliflozin
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT06653738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06653738.